Utah Retirement Systems continued to hold its stake in Humana Inc. (NYSE:HUM) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 27,377 shares of the insurance provider’s stock at the end of the third quarter. Utah Retirement Systems’ holdings in Humana were worth $4,842,000 at the end of the most recent reporting period.

Other hedge funds have also added to or reduced their stakes in the company. Bank of Montreal Can purchased a new position in Humana during the second quarter valued at approximately $14,049,000. Retirement Systems of Alabama increased its position in Humana by 0.7% in the second quarter. Retirement Systems of Alabama now owns 75,981 shares of the insurance provider’s stock valued at $13,667,000 after buying an additional 531 shares during the last quarter. Advisor Partners LLC increased its position in Humana by 3.3% in the second quarter. Advisor Partners LLC now owns 2,283 shares of the insurance provider’s stock valued at $411,000 after buying an additional 72 shares during the last quarter. Zurich Insurance Group Ltd FI increased its position in Humana by 3.7% in the second quarter. Zurich Insurance Group Ltd FI now owns 20,144 shares of the insurance provider’s stock valued at $3,624,000 after buying an additional 724 shares during the last quarter. Finally, Hermes Investment Management Ltd. increased its position in Humana by 8.6% in the second quarter. Hermes Investment Management Ltd. now owns 208,145 shares of the insurance provider’s stock valued at $37,441,000 after buying an additional 16,500 shares during the last quarter. Hedge funds and other institutional investors own 91.71% of the company’s stock.

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Shares of Humana Inc. (NYSE:HUM) traded up 1.26% on Wednesday, hitting $212.64. The stock had a trading volume of 2,125,028 shares. Humana Inc. has a 1-year low of $150.00 and a 1-year high of $212.94. The firm has a 50-day moving average of $182.87 and a 200 day moving average of $177.74. The company has a market capitalization of $31.70 billion, a PE ratio of 28.75 and a beta of 0.80.

Humana (NYSE:HUM) last released its quarterly earnings data on Friday, November 4th. The insurance provider reported $3.18 earnings per share for the quarter, beating analysts’ consensus estimates of $3.09 by $0.09. Humana had a net margin of 2.00% and a return on equity of 12.32%. The business earned $13.69 billion during the quarter, compared to analyst estimates of $13.41 billion. During the same period in the previous year, the business earned $2.16 EPS. Humana’s revenue was up 2.5% compared to the same quarter last year. On average, equities analysts anticipate that Humana Inc. will post $9.51 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 27th. Investors of record on Thursday, January 12th will be paid a $0.29 dividend. The ex-dividend date is Tuesday, January 10th. This represents a $1.16 dividend on an annualized basis and a yield of 0.55%. Humana’s dividend payout ratio is 15.96%.

ILLEGAL ACTIVITY NOTICE: This piece was first published by Daily Political and is owned by of Daily Political. If you are accessing this piece on another site, it was stolen and reposted in violation of United States and international copyright and trademark legislation. The original version of this piece can be viewed at http://www.dailypolitical.com/2016/11/30/humana-inc-hum-position-held-by-utah-retirement-systems.html.

Several equities analysts have recently commented on the company. Credit Suisse Group AG raised Humana from a “neutral” rating to an “outperform” rating and upped their target price for the company from $175.00 to $210.00 in a research report on Friday, November 11th. JPMorgan Chase & Co. raised Humana from a “neutral” rating to an “overweight” rating and upped their target price for the company from $163.00 to $202.00 in a research report on Thursday, November 10th. Barclays PLC reaffirmed a “hold” rating and issued a $191.00 target price on shares of Humana in a research report on Monday, November 7th. Jefferies Group reaffirmed a “buy” rating and issued a $206.00 target price on shares of Humana in a research report on Monday, November 7th. Finally, Susquehanna reaffirmed a “neutral” rating and issued a $180.00 target price on shares of Humana in a research report on Thursday, October 13th. Five analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. Humana presently has an average rating of “Buy” and a consensus target price of $205.00.

About Humana

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

5 Day Chart for NYSE:HUM

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM).

Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.